Patient info Search Menu

BUSCOPAN Ampoules 20 mg/ml solution for injection – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
20 mg / ml
Other strengths and forms:
Contains active substance:
Similar medicines?:

Patient leaflet - Buscopan ampoules 20 mg / ml

1. WHAT BUSCOPAN AMPOULES ARE AND WHAT THEY ARE USED FOR

The name of your medicine is BUSCOPAN Ampoules 20 mg/ml Solution for injection (called BUSCOPAN Ampoules in this leaflet).

BUSCOPAN Ampoules contain a medicine called ‘hyoscine butylbromide’. This belongs to a group of medicines called ‘antispasmodics’.

BUSCOPAN Ampoules are used to relieve cramps in the muscles of your:

  • Stomach
  • Gut (intestine)
  • Bladder and the tubes leading to the outside of your body (urinary system)

BUSCOPAN Ampoules can also be used in some diagnostic and therapeutic medical procedures where spasm may be a problem for example barium enema.

2. BEFORE YOU RECEIVE BUSCOPAN AMPOULES

You should not be given BUSCOPAN Ampoules if:

  • You are allergic (hypersensitive) to hyoscine butylbromide or any of the other ingredients (listed in Section 6)
  • You have glaucoma (an eye problem)
  • You have megacolon (a very enlarged bowel)
  • You have something called ‘myasthenia gravis’ (a very rare muscle weakness problem)
  • You have a very fast heart rate
  • You have difficulty or pain passing water (urine) such as men with prostate problems
  • You have gut blockage problems or a totally inactive gut
  • You are pregnant, likely to get pregnant or are breast-feeding

You should not receive this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking this medicine.

Take special care with BUSCOPAN Ampoules

Check with your doctor or pharmacist before having this medicine if:

  • You have any heart problems
  • You have a fever
  • You have problems with your thyroid gland such as an overactive thyroid gland

If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before receiving BUSCOPAN Ampoules.

Check with your doctor or pharmacist straight away if you have unexplained abdominal pain which persists or worsens or occurs with:

  • fever
  • feeling sick
  • being sick
  • changes in your bowel movements
  • abdominal tenderness
  • low blood pressure
  • feeling faint or,
  • blood in your bowel movements

Taking other medicines

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription and herbal medicines. This is because BUSCOPAN Ampoules can affect the way some other medicines work. Also some other medicines can affect the way BUSCOPAN Ampoules work.

In particular tell your doctor or pharmacist if you are taking any of the following:

  • Medicines for depression called ‘tetracyclic antidepressants’ or ‘tricyclic antidepressants’ such as doxepin
  • Medicines for allergies and travel sickness called ‘antihistamines’
  • Medicines to control your heart beat such as quinidine or disopyramide
  • Medicines for severe mental illness such as haloperidol or fluphenazine
  • Medicines usually used for breathing problems such as salbutamol, ipratropium, tiotropium or atropine-like medicines
  • Amantadine - for Parkinson’s disease and flu
  • Metoclopramide - for feeling sick (nausea) If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before receiving BUSCOPAN Ampoules.

Pregnancy and breast-feeding

You should not be given BUSCOPAN Ampoules if you are pregnant, likely to get pregnant or are breast-feeding.

Driving and using machines

Some people may have sight problems or feel dizzy while taking this medicine. If this happens to you, wait until your sight returns to normal or you stop feeling dizzy before driving or using any tools or machines.

Important information about some of the ingredients of BUSCOPAN Ampoules

BUSCOPAN Ampoules contain sodium chloride. The amount of sodium in a 1 ml ampoule is less than 1 mmol (23 mg), the total amount of sodium if you are given five ampoules in 24 hours is less than 1 mmol (23 mg) this means that your medicine is essentially sodium free.

3. HOW BUSCOPAN AMPOULES WILL BE GIVEN

BUSCOPAN Ampoules are usually given by a doctor or nurse. BUSCOPAN Ampoules should not be given every day for long periods of time.

Receiving the injection

BUSCOPAN Ampoules may be given in two ways:

  • By being slowly injected into a vein
  • By an injection into a muscle
  • BUSCOPAN Ampoules may be diluted with other solutions if needed

How much will you be given

  • You will usually be given one ampoule, but you may be given a further ampoule after half an hour if required
  • If you are being given BUSCOPAN Ampoules as part of an endoscopy your dose may need to be given more often
  • You should not be given more than 5 ampoules in any 24-hour period

BUSCOPAN Ampoules are not recommended for children.

If you have more BUSCOPAN Ampoules than you should

It is unlikely that you will be given too much of this medicine. However, tell the doctor or nurse if you think that you have been given too much.

4. POSSIBLE SIDE EFFECTS

Like all medicines, BUSCOPAN Ampoules can cause side effects although not everybody gets them. The following side effects may happen with this medicine.

Stop taking your medicine and see a doctor straight away, if you notice any of the following serious side effects - you may need urgent medical treatment:

  • Allergic reactions such as skin rash, nettle rash, redness of the skin and itching
  • Severe allergic reactions (anaphylaxis) such as difficulty breathing, feeling faint or dizzy (shock)
  • Painful red eye with loss of vision

Other side effects

  • Dry mouth (affects fewer than 1 in 10 people)
  • Dizziness (affects fewer than 1 in 10 people)
  • Blurred vision (affects fewer than 1 in 10 people)
  • Increased heart rate (affects fewer than 1 in 10 people)
  • Constipation
  • Abnormal sweating or reduced sweating
  • Being unable to pass water (urine)
  • Low blood pressure, for example feeling faint
  • Flushing
  • Dilated pupils
  • Increased fluid pressure inside the eye

Pain at the place you had the injection may occur if you have been given BUSCOPAN Ampoules into a muscle.

Although unlikely, in certain circumstances it may be possible that BUSCOPAN may pass into the brain and cause side effects, for example confusion.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

United Kingdom

Yellow Card scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

5. HOW TO STORE BUSCOPAN AMPOULES

  • Keep out of the reach and sight of children
  • Store below 30°C, keep the ampoules in the outer carton in order to protect from light
  • BUSCOPAN Ampoules should not be used after the expiry date which is printed on the carton and ampoules. The expiry date refers to the last day of that month

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. FURTHER INFORMATION

What BUSCOPAN Ampoules contain

Each ampoule contains 20 mg of the active ingredient hyoscine butylbromide. The other ingredients are sodium chloride and water for injections.

What BUSCOPAN Ampoules looks like and contents of the pack

BUSCOPAN Ampoules are clear glass ampoules with coloured identification rings, containing a colourless or almost colourless, clear solution.

BUSCOPAN Ampoules are supplied in cartons containing 10 ampoules, each containing 1 ml of injectable solution.

Marketing Authorisation Holder and Manufacturer

The Marketing Authorisation is held by:

Opella, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, United Kingdom.

Manufacturer:

Sanofi S.r.l

Vla Valcanello 4,

03012 Anagni (FR),

Italy

This leaflet was revised in May 2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 61186/0002

Last revision stated in the text: May 2026 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Buscopan ampoules 20 mg / ml

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substance? Hyoscine butylbromide
Strength? 20 mg / ml
Pharmaceutical form? Solution for injection
A colourless or almost colourless, clear solution.
How is it taken? Intravenous, Intramuscular
Excipients? Sodium Chloride, Water for injections
Pack sizes 10 ampoule
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? Unopened: 36 months
Once opened, use immediately and discard any unused contents
Storage Store below 30°C.
Store in outer carton.
Drug group (ATC)?
  1. A Alimentary tract and metabolism drugs
    1. A03 Drugs for functional gastrointestinal disorders
      1. A03B Belladonna and derivatives containing drugs, plain for functional gastrointestinal disorders
        1. A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds for functional gastrointestinal disorders
          1. A03BB01 butylscopolamine
Marketing authorisation? PL 61186/0002 (first authorised 23 June 2006)
Marketing authorisation holder? Opella POM UK Limited, trading as Opella
Codes? GTIN 5000283659983 · BNF 01020000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.